EUVIMEDEUVIMED entdecken
Vergleichsstudie

Development of a Visually Calculated SUV mean (HIT Score) on Screening PSMA PET/CT to Predict Treatment Response to 177 Lu-PSMA Therapy: Comparison with Quantitative SUV mean and Patient Outcomes

Mina Swiha, Nathan Papa, Zahra Sabahi, Narjess Ayati, Nikeith John, Sarennya Pathmanandavel, Megan Crumbaker, Sherrington Li, Shikha Agrawal, Maria Ayers, Adam Hickey, Shikha Sharma und 2 weitere

Journal of Nuclear Medicine · 2024-06 · 65 (6) · 904-908

DOI: 10.2967/jnumed.123.267014 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 18.04.2024. Verfasst von Mina Swiha und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Lutetium, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyLutetiumProstatic Neoplasms, Castration-ResistantHumansMaleTreatment OutcomeAgedMiddle AgedHeterocyclic Compounds, 1-RingDipeptidesProstate-Specific AntigenEdetic AcidGallium RadioisotopesImage Processing, Computer-AssistedGallium Isotopes

Stichwörter der Autor:innen

177Lu-PSMAPSMA PET/CTSUVmeanprostate cancer

Substanzen

LutetiumPluvictoHeterocyclic Compounds, 1-RingDipeptidesProstate-Specific AntigenEdetic AcidGallium Radioisotopesgallium 68 PSMA-11Gallium Isotopes

Autor:innen und Institutionen

  • Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.
  • Nuclear Medicine Division, Department of Medical Imaging, University of Western Ontario, London, Ontario, Canada.
  • Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
  • St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia; and.
  • Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, New South Wales, Australia.
  • Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia; louise.emmett@svha.org.au.

Zitieren

APA

Swiha, M., Papa, N., Sabahi, Z., Ayati, N., John, N., Pathmanandavel, S., Crumbaker, M., Li, S., Agrawal, S., Ayers, M., Hickey, A., Sharma, S., Nguyen, A., & Emmett, L. (2024). Development of a Visually Calculated SUV mean (HIT Score) on Screening PSMA PET/CT to Predict Treatment Response to 177 Lu-PSMA Therapy: Comparison with Quantitative SUV mean and Patient Outcomes. Journal of Nuclear Medicine, 65(6), 904-908. https://doi.org/10.2967/jnumed.123.267014

Vancouver

Swiha M, Papa N, Sabahi Z, Ayati N, John N, Pathmanandavel S, et al. Development of a Visually Calculated SUV mean (HIT Score) on Screening PSMA PET/CT to Predict Treatment Response to 177 Lu-PSMA Therapy: Comparison with Quantitative SUV mean and Patient Outcomes. Journal of Nuclear Medicine. 2024;65(6):904-908. doi:10.2967/jnumed.123.267014

BibTeX
@article{Swiha2024,
  author = {Swiha, Mina and Papa, Nathan and Sabahi, Zahra and Ayati, Narjess and John, Nikeith and Pathmanandavel, Sarennya and Crumbaker, Megan and Li, Sherrington and Agrawal, Shikha and Ayers, Maria and Hickey, Adam and Sharma, Shikha and Nguyen, Andrew and Emmett, Louise},
  title = {Development of a Visually Calculated SUV mean (HIT Score) on Screening PSMA PET/CT to Predict Treatment Response to 177 Lu-PSMA Therapy: Comparison with Quantitative SUV mean and Patient Outcomes},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  volume = {65},
  number = {6},
  pages = {904--908},
  doi = {10.2967/jnumed.123.267014}
}
Kostenlos starten →